Vardy, J., Dhillon, H., Pond, G., Rourke, S., Bekele, T., Renton, C., Dodd, A., Zhang, H., Beale, P., Clarke, S., et al (2015). Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study. Journal of Clinical Oncology, 33(34), 4085-4092. [More Information] Arzuman, L., Beale, P., Proschogo, N., Yu, J., Huq, F. (2015). Combination of genistein and cisplatin with two designed monofunctional platinum agents in human ovarian tumour models. Anticancer Research: international journal of cancer research and treatment, 35(11), 6027-6039. Moth, E., Parry, J., Stockler, M., Beale, P., Blinman, P., Della Fiorentina, S., Kiely, B. (2015). Doctor to doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors. Internal Medicine Journal, 45(9), 909-915. [More Information] Arzuman, L., Beale, P., Yu, J., Huq, F. (2015). Monofunctional platinum-containing pyridine-based ligand acts synergistically in combination with the phytochemicals curcumin and quercetin in human ovarian tumour models. Anticancer Research: international journal of cancer research and treatment, 35(5), 2783-2794. Oza, A., Cook, A., Pfisterer, J., Embleton, A., Ledermann, J., Pujade-Lauraine, E., Kristensen, G., Carey, M., Beale, P., Cervantes, A., et al (2015). Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. The Lancet Oncology, 16(8), 928-936. [More Information] Tan, C., Read, J., Phan, V., Beale, P., Peat, J., Clarke, S. (2015). The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study. Supportive Care in Cancer, 23(2), 385-391. [More Information] Huq, F., Yu, J., Beale, P., Chan, C., Arzuman, L., Nessa, M., Mazumder, M. (2014). Combinations of Platinums and Selected Phytochemicals as a Means of Overcoming Resistance in Ovarian Cancer. Anticancer Research: international journal of cancer research and treatment, 34(1), 541-545. Oh, B., Butow, P., Boyle, F., Beale, P., Costa, D., Pavlakis, N., Bell, D., Davis, E., Choi, S., Lee, M., Clarke, S., et al (2014). Effects of Qigong on Quality of Life, Fatigue, Stress, Neuropathy, and Sexual Function in Women with Metastatic Breast Cancer: A Feasibility Study. International Journal of Physical Medicine & Rehabilitation, 2(4), 1-6. [More Information] Wu, J., Ludlow, J., De Vries, B., Black, K., Beale, P. (2014). Single-dose methotrexate treatment for ectopic pregnancy and pregnancy of unknown location and progesterone as a predictor of success. Australian and New Zealand Journal of Obstetrics and Gynaecology, 54(5), 469-474. [More Information] Arzuman, L., Beale, P., Chan, C., Yu, J., Huq, F. (2014). Synergism from Combinations of tris(benzimidazole) monochloroplatinum(II) Chloride with Capsaicin, Quercetin, Curcumin and Cisplatin in Human Ovarian Cancer Cell Lines. Anticancer Research: international journal of cancer research and treatment, 34(10), 5453-5464. Hamad, S., Beale, P., Yu, J., Huq, F. (2014). Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres. Journal of Biomedical Science, 21(1), 1-12. [More Information] Hamad, S., Beale, P., Yu, J., Huq, F. (2014). Synthesis and Antitumour Activity of a New Trinuclear Platinum Compound [{cis-PtCI(NH3)2u {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] CI4 in Human Ovarian Cancer Cells. Anticancer Research: international journal of cancer research and treatment, 34(4), 1923-1929. Arzuman, L., Beale, P., Yu, J., Proschogo, N., Huq, F. (2014). Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models. Anticancer Research: international journal of cancer research and treatment, 34(12), 7077-7090. Al-Eisawi, Z., Beale, P., Chan, C., Yu, J., Huq, F. (2013). Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumor models. Journal of Ovarian Research, 6(Nov 2013), 1-11. [More Information] Vardy, J., Dhillon, H., Clarke, S., Olesen, I., Leslie, F., Warby, A., Beith, J., Sullivan, A., Hamilton, A., Beale, P., Rittau, A., McLachlan, A. (2013). Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. SpringerPlus, 2(1), 1-5. [More Information] Stark, D., Nankivell, M., Pujade-Lauraine, E., Kristensen, G., Elit, L., Stockler, M., Hilpert, F., Cervantes, A., Brown, J., Lanceley, A., et al (2013). Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. Lancet Oncology, 14(3), 236-243. [More Information] Deqnah, N., Yu, J., Beale, P., Fisher, K., Huq, F. (2013). Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models. Medicinal Chemistry, 9(4), 539-544. [More Information] Lim, S., Wilson, S., Hunter, A., Jane, H., Beale, P. (2013). Takotsubo Cardiomyopathy and 5-Fluorouracil: Getting to the Heart of the Matter. Case Reports in Oncological Medicine, 2013, 206765. [More Information] Kiely, B., Martin, A., Tattersall, M., Nowak, A., Goldstein, D., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Stockler, M., et al (2013). The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' Estimates. Journal of Clinical Oncology, 31(28), 3565-3571. [More Information] Kiely, B., McCaughan, G., Christodoulou, S., Beale, P., Grimison, P., Trotman, J., Tattersall, M., Stockler, M. (2013). Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Supportive Care in Cancer, 21(2), 369-376. [More Information]